MidFirst Bank
Source: SEC Form 13F · as of Mar 2026MidFirst Bank holds 13 biotech & pharma companies tracked by BioSniper, totaling $989K in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$989K
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 6,414 | $894K |
| REGNREGENERON PHARMACEUTICALS, INC. | 96 | $74K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 184 | $10K |
| GMABGenmab A/S | 75 | $2K |
| SNYSanofi | 39 | $2K |
| FLNAFilana Therapeutics Inc. | 1,000 | $2K |
| EXELEXELIXIS, INC. | 30 | $1K |
| ROIVRoivant Sciences Ltd. | 46 | $1K |
| TEVATeva Pharmaceutical Industries Limited | 38 | $1K |
| ARGXARGENX SE | 1 | $730 |
| JUNSJUPITER NEUROSCIENCES, INC. | 1,000 | $376 |
| MRNAModerna, Inc. | 5 | $254 |
| OGNOrganon & Co. | 30 | $180 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.